EUVIMEDEUVIMED entdecken
Crossref

A kinetic trap mechanism underlies hHv1 inhibition by NZ-58

Adam Feher iD, Geraldo Jorge Domingos iD, Martina Piga iD, Tihomir Tomašič iD, Nace Zidar iD, Zoltan Varga iD

Journal of General Physiology · 06.07.2026 · 158 (4)

DOI: 10.1085/jgp.202513945 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of General Physiology, online erschienen am 28.05.2026. Verfasst von Adam Feher und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL, USA. Hauptthemen laut MEDLINE: Antiviral Agents, Imidazoles. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Slovenian Research Agency, National Research Development and Innovation Office, Count István Tisza Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A recent publication by our research team has introduced a novel group of hHv1 inhibitors, the 5-phenyl-2-aminoimidazoles. To guide rational drug design of selective derivatives, our goal was to map the molecular mechanism of compound 13 (i.e., NZ-58), a potent member of the series. For this, we utilized site-directed mutagenesis and conventional patch-clamp technique. Applying NZ-58 at various membrane potentials, and using different pulse frequencies, we could unveil the binding mode, which showed closed-state inhibition and no use dependence. The changes in inhibition of mutated hHv1 constructs confirmed the binding pocket suggested by molecular docking comprising countercharges D112 and D185. Combining the results of ionic and gating current measurements revealed an interesting molecular mechanism that traps the S4 helix. Knowing the interacting partners of NZ-58, this mechanism aligned well with previously found functional models of hHv1. By integrating pharmacological and biophysical perspectives, this work lays the groundwork for future advancements in rational drug design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsImidazolesMutagenesis, Site-DirectedKineticsMolecular Docking SimulationHumansBinding Sites

Substanzen

Antiviral AgentsImidazoles

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL, USA.
  • Center for Mechanical Excitability, The University of Chicago , Chicago, IL, USA.
  • Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.

ORCID-Profile: Adam Feher, Geraldo Jorge Domingos, Martina Piga, Tihomir Tomašič, Nace Zidar, Zoltan Varga

Förderung

  • Slovenian Research Agency
  • National Research Development and Innovation Office
  • Count István Tisza Foundation
  • Tempus Public Foundation
  • National Research, Development and Innovation Fund

Zitieren

APA

Feher, A., Domingos, G. J., Piga, M., Tomašič, T., Zidar, N., & Varga, Z. (2026). A kinetic trap mechanism underlies hHv1 inhibition by NZ-58. Journal of General Physiology, 158(4). https://doi.org/10.1085/jgp.202513945

Vancouver

Feher A, Domingos GJ, Piga M, Tomašič T, Zidar N, Varga Z. A kinetic trap mechanism underlies hHv1 inhibition by NZ-58. Journal of General Physiology. 2026;158(4). doi:10.1085/jgp.202513945

BibTeX
@article{Feher2026,
  author = {Feher, Adam and Domingos, Geraldo Jorge and Piga, Martina and Tomašič, Tihomir and Zidar, Nace and Varga, Zoltan},
  title = {A kinetic trap mechanism underlies hHv1 inhibition by NZ-58},
  journal = {Journal of General Physiology},
  year = {2026},
  volume = {158},
  number = {4},
  doi = {10.1085/jgp.202513945}
}
Kostenlos starten →